Relationship between Metabolic Response on Integrated Time-Of-Flight FDG PET/MRI and Pathologic Treatment Response in Patients with FDG-Avid Borderline Resectable Pancreas Cancer Undergoing Neoadjuvant Therapy: A Feasibility Study

Conclusions: FDG PET/MRI shows promise for response evaluation following NAT with complete metabolic response by PET/MRI correlating with marked or complete pathologic response.

Source: Journal of Nuclear Medicine - May 23, 2018 Category: Nuclear Medicine Authors: Garg, I., Samreen, N., Fletcher, J., Truty, M., Johnson, G., Fidler, J., Kemp, B., Goenka, A. Tags: GI Non-Colorectal Posters Source Type: research